Global High Throughput Screening (HTS) Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2026

MarketResearch.biz delivers in-depth insights on the global high throughput screening (HTS) market in its upcoming report titled, “Global High Throughput Screening (HTS) Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global high throughput screening (HTS) market is estimated to register a CAGR of XX.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global high throughput screening (HTS) market report has been segmented on the basis of technology, application, end-users, and region.

Request Covid - 19 Impact

This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.

A drug discovery method that automatically screens large number of biological effectors and modulators against selected target is called as high throughput screening (HTS). High throughput screening aids in easy evaluation of biological activity of large number of drug-like compound so as to discover enzymes, ion-channels, ligands for receptors, or other pharmacological targets for pharmacologically profiling of cellular or biochemical pathway of selected target.

Increasing adoption of open innovative models and advanced drug discovery techniques by pharmaceuticals and biochemical companies is a major factor driving growth of the global high throughput screening market. In addition, rising government and private investments coupled with increasing R&D spending are other factors propelling growth of the global market.

High capital investment is a major factor hampering growth of the global high throughput screening (HTS) market. In addition, lack of skilled professionals in developing and underdeveloped countries is another factor expected to hamper growth of the global market to a certain extent.

The North America market dominates the global high throughput screening (HTS) market in terms of revenue and is expected to maintain its dominance over the forecast period. Presence of advanced healthcare infrastructure, and rising investments by government and private players are major factors driving growth of the North America high throughput screening (HTS) market. The Europe Market accounts for second highest share in terms of revenue in the global market. The Europe high throughput screening (HTS) market is expected to witness significant growth and is expected to register a CAGR of X.X% over the forecast period. The Asia Pacific high throughput screening (HTS) market is expected to witness highest growth and is projected to register a CAGR of XX.X% over the next 10 years. This growth can be attributed to rapid development in healthcare infrastructure and increasing adoption of new technologies by key players in countries in this region.

Global high throughput screening (HTS) market segmentation:

Segmentation on the basis of technology:

• Ultra High-throughput Screening
• Cell-Based Assays
• Lab-On-A-Chip
• Label-Free Technology

Segmentation on the basis of application:

• Drug discovery programs
• Chemical biology programs
• Biochemical screening
• Cell- & organ-based screening

 Segmentation on the basis of end-user:

• Pharmaceutical and Biotechnology
• Academia and Research Institutes
• Contract Research Organization

Segmentation on the basis of region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Agilent Technologies Inc.
• Thermo Fisher Scientific Inc.
• Axxam SpA
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Hamilton Company
• PerkinElmer Inc.
• Danaher Corporation
• GE Healthcare
• Merck KGaA
• Tecan Group Ltd
• Aurora Biomed